Quadrature Capital Ltd Invests $221,000 in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Quadrature Capital Ltd acquired a new position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the 3rd quarter, HoldingsChannel.com reports. The firm acquired 1,700 shares of the medical instruments supplier’s stock, valued at approximately $221,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Canada Pension Plan Investment Board acquired a new position in shares of Mesa Laboratories during the second quarter worth $26,000. FMR LLC boosted its position in shares of Mesa Laboratories by 34.1% in the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 100 shares in the last quarter. Quantbot Technologies LP purchased a new position in Mesa Laboratories during the 3rd quarter worth $70,000. Berry Wealth Group LP acquired a new position in Mesa Laboratories during the 3rd quarter valued at about $204,000. Finally, Amalgamated Bank increased its position in Mesa Laboratories by 6.5% during the 3rd quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier’s stock valued at $206,000 after buying an additional 97 shares in the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on MLAB shares. Evercore ISI raised their price target on Mesa Laboratories from $120.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Wells Fargo & Company started coverage on shares of Mesa Laboratories in a research note on Tuesday, August 27th. They issued an “underweight” rating and a $120.00 target price for the company. Finally, StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

Insider Activity at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 2,518 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $113.62, for a total transaction of $286,095.16. Following the sale, the chief executive officer now directly owns 45,888 shares of the company’s stock, valued at approximately $5,213,794.56. This trade represents a 5.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Brian David Archbold sold 1,499 shares of Mesa Laboratories stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $125.00, for a total value of $187,375.00. The disclosure for this sale can be found here. 4.40% of the stock is owned by insiders.

Mesa Laboratories Stock Performance

Shares of MLAB opened at $128.86 on Wednesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70. The stock has a 50-day moving average of $120.06 and a two-hundred day moving average of $114.90. The stock has a market cap of $699.71 million, a P/E ratio of -2.83 and a beta of 0.86. Mesa Laboratories, Inc. has a one year low of $83.68 and a one year high of $141.17.

Mesa Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 29th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend is Friday, November 29th. Mesa Laboratories’s dividend payout ratio (DPR) is -1.40%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.